Jeffrey Sager is a Respiratory physician. OpenAlex indexes 71 publications with 993 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2428 Castillo St Ste D
Santa Barbara, CA 931055311
Telephone
805-845-1500Provider last certified this registry record 8 Feb 2022.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202530 payments$35,360openpaymentsdata.cms.gov ↗
- Actelion Pharmaceuticals US, Inc.Program year202519 payments$15,097openpaymentsdata.cms.gov ↗
- Chiesi USA, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
30.7%Corticosteroid14.6%Trelegy Ellipta50%Breo Ellipta21%Breztri Aerosphere9%Symbicort7%Fluticasone Propionate5%Breyna4%Arnuity Ellipta4%Part D<11 patientsbeta2-Adrenergic Agonist9.2%Albuterol Sulfate Hfa87%Ventolin Hfa13%Part D≥104 patients+ 4 more classes in this area
Cardiovascular
29.2%Endothelin Receptor Antagonist7.9%Opsumit62%Ambrisentan33%Opsynvi6%Part D<11 patientsStatin5.4%Rosuvastatin Calcium57%Atorvastatin Calcium36%Simvastatin6%Part D<11 patients+ 11 more classes in this area
Anti-infectives
9%Macrolide Antimicrobial4.3%Azithromycin100%Part D≥68 patientsPenicillins with extended spectrum1.2%Amoxicillin-Clavulanate Potass100%Part D≥30 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Medication Nonadherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR)
Annals of the American Thoracic Society
2025 - Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”